BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22917148)

  • 1. Relationship between genetic risk factors and markers for Alzheimer's disease pathology.
    Elias-Sonnenschein LS; Bertram L; Visser PJ
    Biomark Med; 2012 Aug; 6(4):477-95. PubMed ID: 22917148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
    Lambert JC; Amouyel P
    Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.
    Dong HK; Gim JA; Yeo SH; Kim HS
    Gene; 2017 Jan; 597():10-16. PubMed ID: 27773727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.
    Kauwe JS; Cruchaga C; Karch CM; Sadler B; Lee M; Mayo K; Latu W; Su'a M; Fagan AM; Holtzman DM; Morris JC; ; Goate AM
    PLoS One; 2011 Feb; 6(2):e15918. PubMed ID: 21347408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of deleterious single nucleotide polymorphisms in late-onset Alzheimer disease susceptibility genes.
    Masoodi TA; Al Shammari SA; Al-Muammar MN; Alhamdan AA; Talluri VR
    Gene; 2013 Jan; 512(2):429-37. PubMed ID: 22960267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
    Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
    Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
    Carter CJ
    Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of common and disease specific variants in CLU, CR1, and PICALM.
    Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
    Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
    Corneveaux JJ; Myers AJ; Allen AN; Pruzin JJ; Ramirez M; Engel A; Nalls MA; Chen K; Lee W; Chewning K; Villa SE; Meechoovet HB; Gerber JD; Frost D; Benson HL; O'Reilly S; Chibnik LB; Shulman JM; Singleton AB; Craig DW; Van Keuren-Jensen KR; Dunckley T; Bennett DA; De Jager PL; Heward C; Hardy J; Reiman EM; Huentelman MJ
    Hum Mol Genet; 2010 Aug; 19(16):3295-301. PubMed ID: 20534741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.
    Jones L; Harold D; Williams J
    Biochim Biophys Acta; 2010 Aug; 1801(8):754-61. PubMed ID: 20420935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.
    Jun G; Naj AC; Beecham GW; Wang LS; Buros J; Gallins PJ; Buxbaum JD; Ertekin-Taner N; Fallin MD; Friedland R; Inzelberg R; Kramer P; Rogaeva E; St George-Hyslop P; ; Cantwell LB; Dombroski BA; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Lunetta KL; Martin ER; Montine TJ; Goate AM; Blacker D; Tsuang DW; Beekly D; Cupples LA; Hakonarson H; Kukull W; Foroud TM; Haines J; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD
    Arch Neurol; 2010 Dec; 67(12):1473-84. PubMed ID: 20697030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.
    Gharesouran J; Rezazadeh M; Khorrami A; Ghojazadeh M; Talebi M
    J Mol Neurosci; 2014 Dec; 54(4):780-6. PubMed ID: 25022885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance.
    Vacínová G; Vejražková D; Lukášová P; Lischková O; Dvořáková K; Rusina R; Holmerová I; Vaňková H; Včelák J; Bendlová B; Vaňková M
    Mol Biol Rep; 2017 Apr; 44(2):227-231. PubMed ID: 28316001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease beyond APOE.
    van Es MA; van den Berg LH
    Nat Genet; 2009 Oct; 41(10):1047-8. PubMed ID: 19786950
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
    Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
    Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific polymerase chain reaction for the detection of Alzheimer's disease-related single nucleotide polymorphisms.
    Darawi MN; Ai-Vyrn C; Ramasamy K; Hua PP; Pin TM; Kamaruzzaman SB; Majeed AB
    BMC Med Genet; 2013 Feb; 14():27. PubMed ID: 23419238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    Blujus JK; Korthauer LE; Awe E; Frahmand M; Driscoll I
    J Alzheimers Dis; 2020; 78(1):309-320. PubMed ID: 32986668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals.
    Lee JH; Cheng R; Barral S; Reitz C; Medrano M; Lantigua R; Jiménez-Velazquez IZ; Rogaeva E; St George-Hyslop PH; Mayeux R
    Arch Neurol; 2011 Mar; 68(3):320-8. PubMed ID: 21059989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.